Posts Tagged ‘cancer survivors’

Healthier Lifestyle Could Prevent 350,000 Cancer Cases

Monday, February 7th, 2011

About 340,000 cancer cases in the United States could be prevented each year if more Americans ate a healthy diet, got regular exercise and limited their alcohol intake.

These types of lifestyle changes could lead to significant reductions in particularly common cancers such as breast (38 percent fewer cases per year), stomach (47 percent fewer) and colon (45 percent fewer) according to according to the World Cancer Research Fund (WCRF).

Cancer is now one of the most significant critical illnesses according to the American Association for Critical Illness Insurance.  “The chances of surving cancer today is good news for millions’ explains Jesse Slome, AACII’s executivce director.  “However, the emotional and financial toll are something most are not prepared for.”

Physical activity is recommended for people of all ages as a means to reduce risks for certain types of cancers and other non-communicable diseases.  

Experts recommend that in order to improve their health and prevent several diseases, adults should do at least 150 minutes of moderate physical activity throughout the week. This can be achieved by simply walking 30 minutes five times per week or by cycling to work daily.

Other healthy lifestyle habits that reduce the risk of cancer include quitting smoking, avoiding secondhand smoke, avoiding excessive sun exposure, and preventing cancer-causing infections.

Cancer is the leading cause of death worldwide. Each year, 12.7 million people are diagnosed with cancer and 7.6 million die from the disease. But 30 percent to 40 percent of cancers can be prevented and one-third can be cured through early diagnosis and treatment, according to the WCRF.

Genetic Code For Type of Cancer Is Cracked

Sunday, January 23rd, 2011

Scientists at Johns Hopkins have deciphered the genetic code for a type of pancreatic cancer. 

The findings described in Science Express online shows that patients whose tumors have certain coding “mistakes” live twice as long as those without them. 

Scientists report learning that each patient with this kind of rare cancer has a unique genetic code that predicts how aggressive the disease is and how sensitive it is to specific treatments.  What this tells us is that it may be more useful to classify cancers by gene type rather than only by organ or cell type according to Jesse Slome director of the American Association for Critical Illness Insurance.

Pancreatic neuroendocrine cancers account for about five percent of all pancreatic cancers. Some of these tumors produce hormones that have noticeable effects on the body, including variations in blood sugar levels, weight gain, and skin rashes while others have no such hormone signal.

Researchers investigated non-hormonal pancreatic neuroendocrine tumors in 68 men and women. Patients whose tumors had mutations in three genes and lived at least 10 years after diagnosis, while more than 60 percent of patients whose tumors lacked these mutations died within five years of diagnosis. 

The Johns Hopkins team, which previously mapped six other cancer types, used automated tools to create a genetic “map” that provides clues to how tumors develop, grow and spread. 

In the first set of experiments, the Johns Hopkins scientists sequenced nearly all protein-encoding genes in 10 of the 68 samples of pancreatic neuroendocrine tumors and compared these sequences with normal DNA from each patient to identify tumor-specific changes or mutations. 

Major funding for the study was provided by the Caring for Carcinoid Foundation, a nonprofit foundation which funds research on carcinoid cancer, pancreatic neuroendocrine cancer, and related neuroendocrine cancers. Additional funding was from the Lustgarten Foundation for Pancreatic Cancer Research, the Sol Goldman Pancreatic Cancer Research Center, the Joseph Rabinowitz Fund for Pancreatic Cancer Research, the Virginia and D.K. Ludwig Fund for Cancer Research, the Raymond and Beverly Sackler Research Foundation, the AACR Stand Up to Cancer’s Dream Team Translational Cancer Research Grant and the National Institutes of Health.

Cancer Costs Will Soar In This Decade

Friday, January 14th, 2011

A new report predicts that by 2020, the annual cost of cancer care in the United States is expected to reach at least $158 billion. 

According to the report from the U.S. National Cancer Institute that’s a 27 percent jump from 2010.  The surge in cost will be largely driven by an aging population that is expected to develop more cases of cancer in the near-term. 

Projected costs could go even higher if the price tag for care rises faster than expected.  Experts described the 2020 cost estimate as “on the low side” according to the American Association for Critical Illness Insurance which tracks medical and health issues impacting aging Americans. 

Cancer is a disease of aging and the population of elderly Americans is expected to rise from 40 million in 2009 to 70 million by 2030 notes Jesse Slome, executive director for the trade group. Improvements in screening mean cancer is becoming more identifiable and treatable, but therapies are becoming increasingly expensive. 

If the trend in survival and costs continue as they have been, then the estimates could be as high as $207 billion by 2020 one reseracher predicted. The report is published online Jan. 12 and in the Jan. 19 print issue of the Journal of the National Cancer Institute

To estimate the cost of cancer treatment, the research team looked at data on 13 cancers in men and 16 in women. Tracking the rate of these cancers and the current costs to treat them in 2010, they were able to project costs in 2020. 

In these calculations researchers assumed that costs would rise by only 2 percent a year.  The largest increases in cost over the period will be for breast cancer at 32 percent and prostate cancer at 42 percent, simply because more people will be living longer with these diseases, the researchers noted. 

For example, while the cost of treating breast cancer remains relatively low (compared to other tumor types), by 2020 this cancer will incur the highest costs — about $20.5 billion — since there are expected to be many more women living with the disease. 

Commenting on the study, Elizabeth Ward, at the American Cancer Society, said that “a big component of the rise in cost is just the growth and aging of the population. We are just going to have more people developing cancer and under treatment for cancer,” she said.

New Study Ties Diet To Less Critical Illness, Longer Life

Monday, December 27th, 2010

December 27, 2010.  According to medical researchers, today’s leading causes of death have shifted from infectious diseases to chronic diseases.  These include cardiovascular disease and cancer.

Both of these illnesses may be affected by diet a study published in the January 2011 issue of the Journal of the American Dietetic Association reveals. 

Researchers examined data regarding the associations of dietary patterns with mortality through analysis of the eating patterns of over 2500 adults between the ages of 70 and 79 over a ten-year period. They found that diets favoring certain foods were associated with reduced mortality.

By 2030, an estimated 973 million adults will be aged 65 or older worldwide according to the American Association for Critical Illness Insurance which tracks data related to critical illnesses. This study sought to determine the dietary patterns of a large and diverse group of older adults, and to explore connections between these dietary patterns with survival over a 10-year period.

Researchers were able to group the participants into six different clusters according to predominant food choices including healthy foods, high-fat dairy products, meat, fried foods, and alcohol and sweets and desserts.

The “Healthy foods” cluster was characterized by relatively higher intake of low-fat dairy products, fruit, whole grains, poultry, fish, and vegetables, and lower consumption of meat, fried foods, sweets, high-calorie drinks, and added fat. The “High fat dairy products” cluster had higher intake of foods such as ice cream, cheese, and 2% and whole milk and yogurt, and lower intake of poultry, low-fat dairy products, rice, and pasta.

The study was unique in that it evaluated participants’ quality of life and nutritional status, through detailed biochemical measures, according to their dietary patterns.

After controlling for gender, age, race, clinical site, education, physical activity, smoking, and total calorie intake, the “High-fat dairy products” cluster had a 40% higher risk of mortality than the “Healthy foods” cluster. The “Sweets and desserts” cluster had a 37% higher risk. No significant differences in risk of mortality were seen between the “Healthy foods” cluster and the “Breakfast cereal” or “Refined grains” clusters.

Cancer Occurs But Deaths Decline

Sunday, July 11th, 2010

According to a report from the American Cancer Society there will be 1,529,560 new cancer cases in the United States in 2010 and 569,490 deaths. 

Death rates for all cancer types fell by 2 percent a year from 2001 to 2006 among men and 1.5 percent per year from 2002 to 2006 in women.  The reduced death rate from cancer was due a decline in smoking, better treatment and earlier detection.

New cases of colorectal cancer fell 3 percent a year in men and 2.2 percent a year for women from 1998 to 2006, while lung cancer rates have fallen in men by 1.8 percent each year since 1991 and finally started leveling off among women.  Cancer remains one iof the primary illnesses impacting Americans according to the American Association for Critical Illness Insurance.

The drops in mortality rates have meant that nearly 800,000 people who would have died prematurely from cancer over the past 20 years did not. 

The overall U.S. death rate from cancer in 2007 was 178.4 per 100,000 people, a 1.3 percent drop from 2006, when the rate was 180.7 per 100,000.

Mortality rates have decreased by 21 percent among men and by 12 percent among women, due primarily to declines in smoking, better treatments, and earlier detection of cancer.  Lung cancer remains the No. 1 cancer killer of both men and women in the United States. Breast cancer comes in No. 2 for women, prostate cancer is the second most common killer of men, and colon cancer is the third leading cause of cancer death for both sexes.

Obesity Linked To Increased Colon Cancer Deaths

Thursday, March 25th, 2010

A new study suggests they may have poorer long-term survival odds than their thinner counterparts if they do develop the disease.  The findings are reported in the journal Clinical Cancer Research.

The report suggests that excess weight may particularly affect male survivors’ long-term prognosis.  The study of nearly 4,400 U.S. adults treated for colon cancer conducted by researchers at the Mayo Clinic found that obese patients were one-quarter to one-third more likely to die over the next eight years than their normal-weight counterparts.

The relationship between obesity and survival appeared stronger among men — possibly, the researchers speculate, because men are more likely than women to have their excess body fat concentrated in the belly.

Abdominal obesity is particularly linked to hormonal effects that, in theory, could contribute to colon cancer development or the cancer’s aggressiveness.

However, whether and how obesity, per se, affects colon cancer survival remains unclear. The current study points to a relationship between obesity and long-term survival, but does not prove that excess body fat directly affects a patient’s prognosis.

The researchers say the findings suggest that people treated for colon cancer should try to maintain a body mass index lower than 30, the cutoff for obesity. Body mass index, or BMI, is a measure of weight in relation to height.

People may think, ‘I already have cancer. What difference does my weight make? notes Jesse Slome, executive director of the American Association for Critical Illness Insurance.  This study suggests the cancer may behave more aggressively if you’re obese.  Milder obesity, however, was linked to a 24 percent higher risk of death.

Drinking Soda Increases Pancreatic Cancer Risk

Tuesday, February 9th, 2010

New research finds that , new research suggests that adult soda drinkers may also engage in other lifestyle habits, such as smoking, which could contribute to the elevated risk. 

The study was a collaboration between the University of Minnesota and National University of Singapore.

The analysis involved more than 60,000 middle-aged or older Chinese Singaporeans. Researchers calculated how much juice and soda the participants drank on average and followed them for 14 years to see how many developed cancer of the pancreas. 

Those who drank two or more sodas a week were 87 percent more likely to develop this kind of tumor than individuals who didn’t consume any soda. 

Researchers found no link between juice consumption and cancer risk, perhaps because fruit juice has less effect than sugary sodas on glucose and insulin levels, the authors noted. 

Previous research in United States. and Europe has suggested an association between sweetened sodas and juices and pancreatic cancer. This is the first study to examine the association in an Asian population, although the authors feel the findings can be extrapolated to Western nations. 

Drinking sugar-sweetened soft drinks has been linked to weight gain, obesity and diabetes. Both obesity and diabetes are associated with higher risk of pancreatic cancer, one of the leading causes of cancer death in the United States. 

The overall number of people developing the malignancy is over 42,000 new cases last year according to the American Association for Critical Illness Insurance.  The non-profit organization tracks data regarding cancer and heart diseases.

Intensive Rectal Cancer Treatment Shows Promise

Monday, February 1st, 2010

The study included individuals with poor-risk rectal cancer.  That means they have a high likelihood of disease recurrence and poor survival odds despite receiving standard chemotherapy and optimum surgery.

Patients underwent 12 weeks of chemotherapy treatment with capecitabine and oxaliplatin, followed by chemoradiotherapy with capecitabine and surgery, followed by another 12 weeks of capecitabine treatment. 

After 36 months, 68 percent of the patients had no cancer progression, and the overall survival rate was 83 percent. After five years, the overall survival rate was 75 percent. 

Tumor downstaging was shown in most patients receiving neoadjuvant treatment with a low incidence of involved [circumferential resection margins (CRMs)] in the surgical specimens.  Before treatment, 90 percent of eligible patients had tumors with CRMs at risk or involved. 

The study was published online Jan. 25 in The Lancet Oncology.

Posted by the American Association for Critical Illness Insurance which tracks information regarding the three primary critical illnesses which impact Americans, cancer, heart attack and stroke.

What To Watch For Early Spotting Of Ovarian Cancer

Saturday, January 30th, 2010

New research from the Cancer Research Center in Seattle shows that women with ovarian cancer are much more likely than healthy women to report symptoms such as abdominal pain, bloating and feeling full quickly after eating.  This is especially true if the symptoms are relatively new and persistent. 

While ovarian cancer is fairly rare, the symptoms are relatively common and possibly explained by less serious conditions.  Thus medical experts note that the ability to predict who has cancer based on symptoms alone is limited. 

Researchers found that for every 100 women in the general population whose symptoms matched those in a widely accepted ovarian cancer symptom index, only one would actually have early-stage ovarian cancer. 

According to the American Association for Critical Illness Insurance, the disease strikes about one in 72 women.  Last year, 21,550 new cases of ovarian cancer were diagnosed among U.S. women; 14,600 deaths were attributed to the disease.  

The study is published in the Jan. 28 online issue of the Journal of the National Cancer Institute notes that finding ways to detect early-stage ovarian cancer is an ongoing challenge.

Ovarian cancer sometimes is found during a pelvic exam, but tumors are often too deep within the body for doctors to detect. In addition, the symptoms of ovarian cancer are often missed or misdiagnosed as other less serious conditions, including menopause, lactose intolerance, irritable bowel syndrome or even depression. 

While nine of 10 women whose ovarian cancer is caught early are alive five years after diagnosis, only about 20 percent of ovarian cancers are found at their early stage, according to the American Cancer Society. 

According to the study findings, women who were diagnosed with cancer were 10 times more likely to experience the symptoms than women without cancer.   Among patients with early-stage disease, about 27 percent experienced the symptoms for at least five months before diagnosis.

Vitamin D May Lower Colon Cancer Risk

Tuesday, January 26th, 2010

Scientists found that those with the highest levels of vitamin D in their blood had as much as a 40 percent lower risk for developing colorectal cancer than those with the lowest levels.
The researchers report however that it is not completely clear if higher intake of the vitamin actually prevents the disease.  ”The findings are definitely food for thought,” explains Jesse Slome, executive director of the American Association for Critical Illness Insurance.  The organization reports that some 1.4 million new cancer cases are diagnosed each year in the United State. 

Medical experts published their findings based on a study of more than 520,000 people from 10 countries in Western Europe. The study participants gave blood samples and filled out diet and lifestyle questionnaires between 1992 and 1998.   They were then tracked for several more years to see what happened to them. 

During the follow-up period, 1,248 of the study participants were diagnosed with colorectal cancer. These participants were compared with a similar group of 1,248 people who were not diagnosed with the disease. 

The researchers cautioned that it’s not clear if there are risks from consuming high levels of vitamin D, which is available in supplements. It is also not known whether supplements are necessary if people reach certain levels through a healthy diet, exercise and moderate exposure to sunlight.

The study authors noted that current recommendations for preventing colorectal cancer include exercising, not smoking, reducing obesity and abdominal fat, and limiting consumption of alcohol and red and processed meats.

Pediatric Cancer Survivors Face Higher Heart Disease Risk

Monday, January 11th, 2010

These risk factors for heart disease are being found at an earlier age than in the general population, according to research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

An estimated 80 million Americans have cardiovascular disease according to the American Association for Critical Illness Insurance 2010 Fact Book.  Someone suffers a heart attack every 34 seconds the report notes.

Researchers at Emory University, extracted data from the Childhood Cancer Survivor Study, which included 8,599 cancer survivors and 2,936 of their siblings.  In data previously published from the Childhood Cancer Survivor Study, pediatric cancer survivors were found to be at almost 10-fold greater risk for cardiovascular disease than their non-survivor counterparts. 

In this study scientists identified whether the predisposing risk factors for cardiovascular disease — obesity, hypertension, hyperlipidemea and diabetes — were present at higher rates compared to siblings. If the risk factors could be recognized and treated early it is hoped some of the long-term cardiac side effects could be averted. 

They found that cancer survivors were nearly twice as likely as their siblings to take medication for high blood pressure, 60 percent more likely to take cholesterol medication and 70 percent more likely to have diabetes. 

Radiation treatment may be playing a role in the development of risk factors for cardiovascular disease.  Total body irradiation was linked with a 5.5-fold increased risk and chest and abdomen radiation a 2.2-fold increased risk of cardiovascular risk factor clustering, which when present is associated with subsequent cardiovascular disease. 

Researchers examined the presence of cardiovascular risk factors and found that physical inactivity among cancer survivors was linked with a 70 percent increased risk for cardiovascular risk factor clustering. Older age at the time of the study was linked to an 8.2-fold increased risk for cardiovascular risk factor clustering among survivors compared with children who had never had cancer.

Calorie Intake Linked To Longevity And Cancer Development

Saturday, December 19th, 2009

According to findings reported by researchers from the University of Alabama at Birmingham,  reducing calorie-intake can benefit longevity and help prevent diseases like cancer that have been linked to aging.

The researchers conducted tests by growing both healthy human-lung cells and precancerous human-lung cells in laboratory flasks. The flasks were provided either normal levels of glucose or significantly reduced amounts of the sugar compound, and the cells then were allowed to grow for a period of weeks.   Restricted glucose levels led the healthy cells to grow longer than is typical and caused the precancerous cells to die off in large numbers.

Every year some 1.4 million Americans are diagnosed with cancer.  It ranks as one of the leading factors for the need for costly long-term care according to the American Association for Critical Illness Insurance among aging seniors.

Two key genes were affected in the cellular response to decreased glucose consumption. The first gene, telomerase, encodes an important enzyme that allows cells to divide indefinitely. The second gene, p16, encodes a well known anti-cancer protein.

Healthy cells saw their telomerase rise and p16 decrease, which would explain the boost in healthy cell growth, the researchers explained.  The research into the links between calorie intake, aging and the onset of diseases related to aging is thought to be a first of its kind given that it used the unique approach of testing human cells versus laboratory animals.

The group’s study titled “Glucose Restriction Can Extend Normal Cell Lifespan and Impair Precancerous Cell Growth Through Epigenetic Control of hTERT and p16 Expression” has been published in the online edition of The Journal of the Federation of American Societies for Experimental Biology, or FASEB Journal.

Radiation From CT Scans May Cause Cancer Risk

Wednesday, December 16th, 2009

Research findings reveal that Americans who are overexposed to radiation from diagnostic tests, especially from a specialized kind of X-ray called a computed tomography, or CT, scan have an increased liability for incurring cancer.

According to the American Association for Critical Illness Insurance, about 70 million CT scans were done on Americans in 2007, up from 3 million in 1980.  A chest CT scan exposes the patient to more than 100 times the radiation dose of a chest X-ray.

Medical researchers at the National Cancer Institute developed a computer model to estimate the impact of scans.  They estimated the scans done in 2007 will cause 29,000 cancers. A third of the projected cancers will occur in people who were ages 35 to 54 when they got their CT, two-thirds will occur in women and 15 percent will arise from scans done in children or teens. 

The researchers estimated there will be an extra 2,000 excess breast cancers just from CT scans done in 2007.  They found radiation dosage varied widely between different types of CT studies, from a median or midpoint of 2 millisieverts for a routine head CT scan to 31 millisieverts for a scan of the abdomen and pelvis, which often involves taking multiple images of the same organ. 

By comparison, the average American is exposed to about 3 millisieverts of radiation a year from ground radon or flying in an airplane — a level not considered a risk to health.

Bone Drugs May Cut Risk Of Breast Cancer

Monday, December 14th, 2009

Reserachers at the University of Pittsburgh Cancer Institute examined studies to determine whether bisphosphonates may actually prevent disease recurrence through a variety of mechanisms.  Bisphosphonates are already used to treat complications that result from breast cancer spreading to the bones. 

According to the American Association for Critical Illness Insurance statistics, nearly 700,000 U.S. women are diagnosed with cancer each year.  Breast cancer is the most common cancer among women. 

One study looked at more than 150,000 postmenopausal women who participated in the U.S. government-led Women’s Health Initiative.  The women taking bisphosphonates, namely Fosamax (alendronate), had a 32 percent reduction in their rate of invasive breast cancer compared to women who were not taking one of these drugs. 

When conducting the study, University of California, Los Angeles, researchers were able to control for the fact that women with low bone mineral density are already at lower risk for breast cancer.  

In another study, Israeli researchers found that postmenopausal women taking bisphosphonates for one or more years had a 29 percent reduction in their risk of breast cancer.  And the tumors that did appear tended to be estrogen receptor-positive and thus easier to treat than estrogen receptor-negative tumors. 

Researchers from the University of Pittsburgh Cancer Institute, concluded that zoledronic acid, another bisphosphonate, is safe and effective for use by postmenopausal women with breast cancer who are being treated with aromatase inhibitors. Bone mineral density increased 6.2 percent in women taking zoledronic acid, compared with 2.4 percent in the control group.

Genetic Test Could Help Spot Breast Cancer

Saturday, December 12th, 2009

New research suggests that within the cell nucleus, chromosomes and individual genes occupy specific locations relative to one another. The organization of these bodies can change for many reasons, but one of them is cancer. 

Researchers from the U.S. National Cancer Institute have honed in on several genes that have a different physical position inside the nucleus in invasive breast cancer cells than in normal breast tissue cells. A change in the position of one gene in particular, HES5, predicted invasive breast cancer nearly all of the time, they found.

The discovery suggests that looking at three-dimensional properties of the cell could one day be used as a new method of diagnosing breast cancer.  Some 1.4 million new cancer cases are diagnosed each year in the U.S., according to the American Association for Critical Illness Insurance.  Breast cancer is the most common cancer among women.

The study published online in the Journal of Cell Biology reports that  while breast tumors are typically detected by a mammogram, which is basically an X-ray of the breast.  The other way of detection occurs when a woman or her doctor feels a lump. To determine if the mass is cancerous or benign, a doctor would order a biopsy, which involves the removal of a small tissue sample that is then analyzed by a pathologist. 

Using 11 normal human breast tissue samples and 14 invasive cancer tissue samples, the researchers identified eight genes that were frequently repositioned in cancer specimens. They found that the repositioning of the gene HES5 indicated breast cancer in nearly all samples. 

Previous research had implicated HES5 with cancer, according to background information in the study. In the new study, the researchers also found that changes in the location of several other combinations of two or three genes also indicated cancer with high accuracy.

Cancer Cases And Deaths Continue to Drop

Thursday, December 10th, 2009

According to the findings of a new report, new cancer cases and deaths from cancer have declined significantly for both men and women and for most racial and ethnic populations.

These decreases were largely due to decreased incidence and death from lung, prostate and colon cancer among men and a drop in two of the three leading cancers in women which include breast and colon cancers. 

Data from the American Cancer Society, the U.S. Centers for Disease Control and Prevention, the U.S. National Cancer Institute and the North American Association of Central Cancer Registries revealed that new diagnoses for all types of cancer in the United States declined almost 1 percent per year from 1999 to 2006 and cancer deaths dropped 1.6 percent per year from 2001 to 2006. 

According to the American Association for Critical Illness Insurance which tracks data for the three primary illnesses afflicting Americans (cancer, heart attack and stroke) there were nearly 1.5 million people with new cancer diagnoses in 2009. 

Cancer rates are still higher for men than for women, but men had the biggest declines in new cases and death, the study revealed.  This year’s report focused on trends in colorectal cancer. Colorectal cancer, the third most-diagnosed cancer in both men and women, is also the second-leading cause of cancer deaths in the United States. 

Overall, colon cancer rates are declining, but the decline is mostly among those over 65. Increasing numbers of cases in men and women under 50 is worrisome, the report noted.  Among both men and women, there were major declines in colorectal cancer cases from 1985 to 1995, minor increases from 1995 to 1998, and significant declines from 1998 to 2006. Since 1984, death rates also dropped, with accelerated rates of decline since 2002 for men and since 2001 for women.

In fact, from 1975 to 2000, cases of colorectal cancer fell 22 percent; 50 percent of which was most likely due to changes in lifestyle, and 50 percent to more people being screened. 

In addition, deaths from colorectal cancer fell 26 percent during the same time; 9 percent of the drop came from lifestyle changes, 14 percent came from screening and 3 percent came from improved treatment, according to the report. 

Going forward, if there were no changes in lifestyle, screening or treatment, there would be a 17 percent drop in colorectal cancer deaths from 2000 to 2020. However, if current trends remain the same, there will be a 36 percent drop in colorectal cancer deaths. 

If more Americans adopted more healthy lifestyles, such as quitting smoking, and were screened for colon cancer and had access to optimal treatment (such as more effective chemotherapy), deaths from colon cancer could be reduced by 50 percent by 2020, the report predicted.

Drinking Coffee Reduces Risk of Advanced Prostate Cancer

Tuesday, December 8th, 2009

Data presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference revealed that coffee has effects on insulin and glucose metabolism as well as sex hormone levels, all of which play a role in prostate cancer. 

Medical researchers report that that men who drank the most coffee had a 60 percent lower risk of aggressive prostate cancer than men who did not drink any coffee. This is the first study of its kind to look at both overall risk of prostate cancer and risk of localized, advanced and lethal disease. 

Some 745,000 men are diagnosed with cancer each year in the United States according to the American Association for Critical Illness Insurance that tracks critical illness data for cancers, heart attack and stroke.  Approximately 300,000 men die each year of cancer. 

The researchers are unsure which components of the beverage are most important, as coffee contains many biologically active compounds like antioxidants and minerals.  They study examined both regular and decaffeinated coffee intake of nearly 50,000 men every four years from 1986 to 2006. 

Nearly 5,000 men developed prostate cancer over that time. The researchers examined the association between coffee consumption and levels of circulating hormones in blood samples collected from a subset of men in the cohort.  The results do suggest there is no reason to stop drinking coffee out of any concern about prostate cancer, the report adds.

More Americans Surviving Lung Cancer

Thursday, December 3rd, 2009

According to the new study, researchers found that one-year overall survival rate for lung cancer increased from 13.2 percent in 1990 to 19.4 percent in 2005, while two-year overall survival increased from 4.5 percent to 7.8 percent. 

Some 1.4 million Americans are diagnosed with cancer according to the American Association for Critical Illness Insurance.  Lung and bronchial cancers account for about 15 percent of all cancer.

Researchers analyzed data on more than 100,000 patients diagnosed with stage 4 non-small cell lung cancer (NSCLC) between 1990 and 2005. The patient information was in the U.S. National Cancer Institute’s Surveillance, Epidemiology and End Results database. 

The study authors noted that the improved survival rates may come from changes in the management of advanced lung cancer over the past two decades, including new chemotherapy agents and regimens, increased use of salvage chemotherapy and the introduction of molecularly targeted therapies. 

The study is published in the December issue of the Journal of Thoracic Oncology.

Study: Breast Cancer Cured But Pain Survives

Wednesday, November 11th, 2009

According to a report in today’s Journal of the American Medical Association the pain exists even two or three years following treatment.  Almost 60% of the over 3,000 women surveyed experience other symptoms of nerve damage, such as numbness or tenderness, according to a study of women treated for breast cancer in 2005 and 2006. 

The researchers noted that women under 40 and those who have more extensive surgery, such as a mastectomy, and radiation are the most likely to report pain.  Women, they report, also have more pain if surgeons removed many of the lymph nodes in their armpits, a common place for breast cancer to spread.

Most breast cancer patients can ease their symptoms with over-the-counter pain relievers.  Every year nearly 700,000 American women are diagnosed with cancer according to the American Association for Critical Illness Insurance.  About one in four women are diagnosed with breast cancer and as a result of early detection and improved treatment, most survice.

 

While the medical experts explain that it is not always possible to prevent chronic pain, there are ways women can reduce their risk.

 

Women should choose doctors who perform “sentinel-node” biopsies, one of the experts writing in the Journal noted. In the procedure, surgeons remove and test one or a few key lymph node for malignant cells instead of automatically removing all of the nodes. If the sentinel node is cancer-free, surgeons leave the others in place. The procedure also reduces the risk of lymphedema, a painful swelling in the arm.

Race, Income, Marital Status Has No Impact On Prostate Cancer Outcome

Thursday, November 5th, 2009

A study conducted at the Henry Ford Hospital in Detroit found that socioeconomic status factors had no impact on predicting the outcome of treatment. All patients did equally well, based on the known prognostic factors. 

The study, presented this week at the American Society for Radiation Oncology meeting in Chicago is unique in that nearly 50 percent of patients in the analysis are African American. 

Prostate cancer affects one in six men in the United States according to the American Association for Critical Illness Insurance and the majority of all prostate cancer are diagnosed in men older than 65.  Most individuals diagnosed with the illness will survive.  Only one in 35 will die of prostate cancer.   Radiation therapy involves administering high-energy X-rays to kill cancer cells. 

According to the study’s lead researcher, prior studies on socioeconomic status and cancer outcomes done by other groups have had conflicting results.  One study, for example, suggested that African Americans with breast or colon cancer do much worse than white patients because they receive care at hospitals with less expertise.

Another study the medical experts noted show that men with prostate cancer who are married have better outcomes than those who are unmarried or without a partner. And yet other studies suggested that hospitals with large minority patient populations have higher mortality for cancer.

A shortcoming of many of the studies is the fact that they include a relatively small percentage of African American patients.  By comparison, almost half of the Ford study group was African American, which allowed researchers to undertake a more accurate assessment of how socioeconomic status affects prostate cancer outcomes.

Well-educated Women Hardest Hit By Breast Cancer

Saturday, October 24th, 2009

A study undertaken by Australia’s Monash University Medical School’s Women’s Health Program, found that well-educated women and those who live alone are emotionally the hardest hit.  Older women tended to similarly experience lower levels of overall well being compared to women of similar age in the community two years after their diagnosis. 

Nearly 1.5 million Americans will be diagnosed with cancer in 2010 according to the American Association for Critical Illness Insurance, the industry trade group, including almost 180,000 breast cancer cases in women.  Breast cancer is the most common cancer among women. With improvements in detection and treatment of breast cancer, 87 per cent of women affected survive five years or more from the time of detection. 

The researchers found that two years post diagnosis women with breast cancer were not more likely to be depressed but were more likely to experience a lowered sense of control over their life, and lower general health, with lessened vitality being limited to older women. 

One researcher explained that the experience of having breast cancer is a personal one and is often accompanied by very complex emotions due to the fact that it strikes at a woman’s very sense of self, purpose and sexuality.

That women living alone were more likely to have a lower well being is a novel and important finding they noted suggesting that such women may benefit by targeted provision of social support.  More educated women are likely to be the best informed about their breast cancer and treatment, and their lower well-being results may reflect greater anxiety over decision making and their difficulty coping with a sense loss of control over their health. 

The study reported that women’s well being two years out from being treated for the disease was overall only modestly lower than for women in general.  The researchers noted that women who struggling with their emotions following breast cancer treatment may benefit from sharing their feelings with those close to them and discussing their concerns with health professionals or participating in breast cancer support group.

Smoking Bans Reduce Heart Attack Occurrence

Monday, October 19th, 2009

A new report from the Institute of Medicine confirms that there is sufficient evidence that breathing secondhand smoke boosts nonsmokers’ risk for heart problems.  The medical researchers added that indirect evidence indicating that even relatively brief exposures could lead to a heart attack is compelling. 

According to the American Association for Critical Illness Insurance, some 43 percent of nonsmoking children and 37 percent of nonsmoking adults are exposed to secondhand smoke in the United States. Experts report that roughly 126 million nonsmokers were still being exposed in 2000.

A 2006 report from the U.S. Surgeon General’s office concluded that exposure to secondhand smoke causes heart disease and indicated that smoke-free policies are the most economical and effective way to reduce exposure. However, the effectiveness of smoking bans in reducing heart problems has continued to be a source of debate.

The Institute of Medicine researchers conducted a comprehensive review of published and unpublished data and testimony on the relationship between secondhand smoke and short-term and long-term heart problems. Eleven key studies that evaluated the effects of smoking bans on heart attack rates informed the committee’s conclusions about the positive effects of smoke-free policies. The studies calculated that reductions in the incidence of heart attacks range from 6 percent to 47 percent. 

The report was sponsored by the U.S. Centers for Disease Control and Prevention. Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides independent, objective, evidence-based advice to policymakers, health professionals, the private sector, and the public.

Prostate Cancer Treatment May Spark Heart Problems

Wednesday, September 23rd, 2009

The findings from new research conducted at King’s College in London could make doctors think twice before prescribing the standard hormone treatment to men with prostate cancer, particularly if they are at risk of heart disease.

More than 670,000 men are diagnosed with prostate cancer globally every year, making it the second-most common cancer in men, after lung cancer.  In the U.S., over 185,000 men are diagnosed with prostate cancer annually according to the American Association for Critical Illness Insurance, the national trade organization.  About 600,000 men are being treated with endocrine therapies for prostate cancer worldwide.

Researchers studied 30,000 men in Sweden with prostate cancer who received hormone therapy between 1997 and 2006. They compared the rate of heart problems in those patients to the rate in the general Swedish population.

Prostate cancer patients had a 28 percent higher relative chance of having a fatal heart attack and a 21 percent increased chance of dying from heart disease.  While these risks were still low in absolute terms, the researchers estimated that the hormone therapies would cause heart problems including a heart attack at the rate of about 10 persons for every 1,000 prostate cancer patients.

Previous studies have found hormone therapy given to prostate cancer patients with a history of heart disease increases their chances of dying.  Scientists believe that male-produced testosterone has some protective effect on the heart. Thus, hormones that interfere with testosterone could be deadly.

Hispanic Americans Have Lower Cancer Risk

Wednesday, September 16th, 2009

Hispanic (Latino) Americans are less likely than non-Hispanic whites to develop and die from all cancers combined as well as the four most common cancers (female breast, prostate, colorectal, and lung) according to a new report.

However, Hispanics have higher rates of several cancers related to infections (stomach, liver, and cervix) and are more likely to have cancer detected at a later stage.

The findings come from the latest edition of Cancer Facts & Figures for Hispanics/Latinos.  Hispanic Americans comprise the largest, fastest-growing, and youngest minority in the United States.  An estimated 98,900 new cancer cases will be diagnosed in Hispanic/Latinos in 2009. Prostate is the most commonly diagnosed cancer in men, while breast cancer is the most common cancer among women. Colorectal cancer is the second-most common cancer in both men and women.

Cancer is the second leading cause of death in the United States, exceeded only by heart disease according to the American Association for Critical Illness Insurance.  More than 1.44 million Americans had a diagnosis of cancer in 2008 and some 565,000 died.  According to the National Institutes of Health, cancer cost the United States an estimated $228 billion in medical costs in 2008.

An estimated 18,800 Hispanics are expected to die from cancer in 2009; the top two causes of cancer death among men are lung and colorectal cancer, while breast and lung cancer are the top two in women.

Between 1997 and 2006, cancer incidence rates decreased among Hispanics by 1.3% per year in men and 0.6% per year in women, compared to decreases of 0.8% per year and 0.4% per year in non-Hispanic white men and women, respectively.

 During the same time period, cancer death rates among Hispanics decreased by 2.2% per year in men and 1.2% per year in women, compared to decreases in non-Hispanic whites of 1.5% per year in men and 0.9% per year in women.

The report also finds that compared to non-Hispanic whites, Hispanic/Latino Americans have a later stage of diagnosis for many cancers, including breast and melanoma and have generally similar 5-year survival, except for melanoma, for which survival rates are lower in Hispanic compared to non-Hispanic white men (79% versus 87%) and women (88% versus 92%).

Written by Jesse Slome from the American Association for Critical Illness Insurance
http://www.criticalillnessinsuranceinfo.org

Obesity, Alcohol, Smoking Increase Risk Of Second Breast Cancer

Thursday, September 10th, 2009

Survivors of breast cancer have a significantly higher risk of developing a second breast cancer than women in the general population have of developing a first breast cancer.   Breast cancer now has a greater than 90 percent five-year survival rate in the United States, according to the American Association for Critical Illness Insurance, the industry trade group.

Considering the large and ever-growing number of survivors, scientists noted that little is known about lifestyle factors may make survivors more vulnerable to a second cancer.

A just published study by researchers at Fred Hutchinson Cancer Research Center finds that obesity, alcohol use and smoking all significantly increase the risk of second breast cancer among breast cancer survivors.

The researchers found that obese women had a 50 percent increased risk, women who consumed at least one alcoholic drink per day had a 90 percent increased risk, and women who were current smokers had a 120 percent increased risk of developing a second breast cancer.

The study adds to a growing body of evidence that obesity, alcohol consumption (consuming at least seven drinks a week) and current smoking may be important risk factors for second breast tumors. The research also suggests that current smokers who imbibe at least seven drinks a week may be at particularly high risk of second breast cancer.

The National Cancer Institute funded the research that was published online in the Journal of Clinical Oncology.

Surviving Cancer Can Depend On Where You Live

Tuesday, September 8th, 2009

Researchers with the New Jersey Department of Health and Senior Services analyzed survival patterns in different areas of New Jersey among 25,040 men and women diagnosed with colorectal cancer from 1996 through 2003, and monitored through 2006.

They found that the number of people who lived at least 5 years after being diagnosed and treated was about 84 to 88 percent in high-income white neighborhoods, compared with 80 percent statewide.

Survival rates were much lower – just 73 percent – “in low income, racially diverse neighborhoods,” they found.  Five-year survival was 83 percent among Caucasians compared with 75, 79, and 80 percent among Blacks, Hispanics, and Asian/Pacific Islanders.   These findings are similar to those from other regions in the U.S. and elsewhere. Taken together, the data provide strong support for the theory that health is affected by many factors, such as biological, behavioral, and environmental traits, the researchers note.

SOURCE: International Journal of Health Geographics, July 23, 2009.

Protein May Identify Breast Cancer

Thursday, August 27th, 2009

German researchers have identified a protein linked to more aggressive and advanced breast cancer tumors.

The scientists studied samples of breast tissue from patients with cancer and compared them with healthy breast tissue.  Researchers found that those whose tumors had elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein tended to have a more advanced stage of cancer, had an increased number of cancerous lymph nodes and a greater chance of death.

Measurement of GLI1 could be a useful for determining cancer prognosis, according to the study which is published this week in the journal BMC Cancer.

More Women Survive Breast Cancer

Thursday, August 27th, 2009

More women are surviving breast cancer in situ according to a report in the current issue of the Journal of the American Medical Association is welcome news for millions of American women.  There were 610,171 in situ survivors in 2005 and reserachers expect that by 2016 the number will exceed one million.

Breast cancer in situ now accounts for 20 percent of newly diagnosed breast cancers. It is the early stage of the disease, when it is still confined to the layer of cells in the ducts or lobules of the breasts.  Cancer is one of the three primary critical illnesses that strikes Americans resulting in billions of dollars of lost productivity and medical expenses according to the American Association for Critical Illness Insurance.

Researchers at the University of Wisconsin-Madison explained that while there were 2.5 million breast cancer survivors in the United States in 2005, the number of breast cancer in situ survivors was unknown.

Women with breast cancer in situ are four times more likely to develop invasive breast cancer compared with the general population, the researchers explained.  The scientists study found that women with ductal breast cancer in situ, one of the more common forms, were more than five times more likely to be survivors compared with women diagnosed with lobular breast cancer in situ.

The researchers also reported that more white women survived than black women and women from other ethnic groups.  “Current epidemiologic evidence regarding predictors of subsequent invasive breast cancer after breast cancer in situ is limited,” the researchers noted in their report. “Guidelines are necessary to help the increasing number of breast cancer in situ survivors choose the best treatment and lifestyle strategies while still maintaining high quality of life.”

SOURCES: Barbara A. Brenner, executive director, Breast Cancer Action, San Francisco; Aug. 26, 2009, Journal of the American Medical Association

Declines In Cancer Deaths

Saturday, August 22nd, 2009

The scientists note that younger adults between ages 35 and 45 years old experienced the steepest declines in cancer death rates.  They noted that all age groups showed some improvement.  The findings of the study appear in the journal Cancer Research.

The news has both positive and negative implications some experts note.  Surviving cancer often results in an enormous financial toll on both the survivor and their family.  According to the American Association for Critical Illness Insurance the industry trade group, uncovered medical costs are a leading cause of personal bankruptcies in the United States.

While U.S. government estimates suggest there had been little improvement in cancer death rates throughout the 20th century, scientists noted the government reports did not tell the whole story.  Researchers used a different way of looking at cancer death rates that measured improvements in cancer deaths by age.

By comparison, government data tends to average all age groups together to produce a composite rate.

Because most cancer deaths occur in older Americans, the average was weighted toward experiences of older people.   Instead, the researchers looked at improvements in cancer deaths among groups of individuals born in five-year intervals starting in 1925.

 Using this methodology, they found that everyone born since the 1930s has enjoyed a decreased risk of cancer death, at every age.  People in the youngest age group (between 35 and 45) had a greater than 25 percent decline per decade in cancer deaths.

Cancer Survivors Face Tough Road After Treatment Ends

Sunday, August 9th, 2009

Cancer survivors are more likely than their healthy peers to suffer serious psychological distress such as depression, even a decade after treatment ends.

According to a study published in the July 27, 2009 issue of the Archives of Internal Medicine, those who were relatively young at the time of diagnosis, unmarried, had less than a high school education, were uninsured, had other illnesses or had difficulty doing the activities of daily living were at the highest risk of psychological problems.

The United States is home to 12 million cancer survivors, or 4 percent of the population, numbers that are expected to rise as cancer screening improves and Baby Boomers age, according to the researchers, from Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston.

To gauge the long-term psychological impact of the disease, they analyzed mental health and medical data on some 4,600 adults who’d survived cancer and over 122,000 who had never had cancer. The data was collected between 2002 and 2006 by the National Health Interview Survey, which is conducted yearly by the U.S. Census Bureau.

During a follow-up period of at least five years and an average of 12 years, about 5.6 percent of cancer survivors were found to have experienced severe psychological distress within the previous month, compared with 3 percent of those without cancer.

Those who are younger, single, have less education and no insurance may suffer more because they have fewer resources to draw from to get through it.   Getting a diagnosis of cancer and going through chemotherapy can be among life’s most trying experiences, said a spokesperson from the American Cancer Society.

The physical and emotional fallout of cancer treatment, including fatigue, pain, nausea and vomiting, mouth sores and hair loss, can contribute to feelings of anxiety and depression.  While many of these symptoms may subside or disappear after treatment ends, some, including fatigue, can linger for months or years.
Chemotherapy can also cause delayed problems that aren’t apparent until months or years later, including peripheral neuropathy (nerve pain or numbness), infertility, organ dysfunction, hearing loss, muscle atrophy and cardiovascular disease.

In the study, 9 percent of long-term cancer survivors and 6 percent of individuals without cancer reported seeing or talking to a mental health professional within the previous year. One-third of cancer survivors with serious psychological distress reported using mental health services, while 18 percent said they could not afford mental health care.